1. 637. Treatment Outcomes in Secondary Analysis Populations of Adult Patients the ALLIUM Phase 3 study Comparing Cefepime-Enmetazobactam to Piperacillin-Tazobactam for Complicated Urinary Tract Infections (cUTI) or Acute Pyelonephritis (AP). (4th December 2021) Authors: Kaye, Keith S; Belley, Adam; Barth, Philip; Lahlou, Omar; Velicitat, Patrick Journal: Open forum infectious diseases Issue: Volume 8(2021)Supplement 1 Page Start: S421 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. LB-4. Cefepime-Enmetazobactam Demonstrates Superiority to Piperacillin-Tazobactam in a Subgroup of Patients with Complicated Urinary Tract Infections/Acute Pyelonephritis Caused by Extended Spectrum β-Lactamase-Producing Enterobacterales. (31st December 2020) Authors: Belley, Adam; Barth, Philip; Kashyap, Shikhar; Lahlou, Omar; Motta, Paola; Knechtle, Philipp; Velicitat, Patrick Journal: Open forum infectious diseases Issue: Volume 7:Number 1(2020) Supplement Page Start: S845 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗